Most cells of the developing mammalian brain derive from the ventricular (VZ) and the subventricular (SVZ) zones. The VZ is formed by the multipotent radial glia/neural stem cells (NSCs) while the SVZ harbors the rapidly proliferative neural precursor cells (NPCs). Evidence from human and animal models indicates that the common history of hydrocephalus and brain maldevelopment starts early in embryonic life with disruption of the VZ and SVZ. We propose that a "cell junction pathology" involving adherent and gap junctions is a fi nal common outcome of a wide range of gene mutations resulting in proteins abnormally expressed by the VZ cells undergoing disruption. Disruption of the VZ during fetal development implies the loss of NSCs whereas VZ disruption during the perinatal period implies the loss of ependyma. The process of disruption occurs in specifi c regions of the ventricular system and at specifi c stages of brain development. This explains why only certain brain structures have an abnormal development, which in turn results in a specifi c neurological impairment of the newborn. Disruption of the VZ of the Sylvian aqueduct (SA) leads to aqueductal stenosis and hydrocephalus, while disruption of the VZ of telencephalon impairs neurogenesis. We are currently investigating whether grafting of NSCs/neurospheres from normal rats into the CSF of hydrocephalic mutants helps to diminish/repair the outcomes of VZ disruption.
INTRODUCTION
It is now understood that hydrocephalus is not only a disorder of CSF dynamics, but also a brain disorder, and that derivative surgery does not resolve most aspects of the disease (Jones and Klinge, 2008) . Indeed, 80-90% of the neurological impairment of neonates with fetal onset hydrocephalus is not reversed by derivative surgery. How can we explain the inborn and, so far, irreparable neurological impairment of children born with hydrocephalus? In 2001, Miyan and his co-workers asked a key question: "Humanity lost: the cost of cortical maldevelopment in hydrocephalus. Is there light ahead?" We think that there is some light. There is evidence that the common history of congenital hydrocephalus and brain maldevelopment starts early in the embryonic life with the disruption of the ventricular (VZ) and subventricular (SVZ) zones. However, the nature, mechanisms and extent of the brain impairment linked to hydrocephalus are far from been fully unfolded. We agree with Del Bigio (2001) and Williams et al., (2007) that better treatment of hydrocephalus and the associated neurological impairment will come from a better understanding of the biological basis of the brain abnormalities in hydrocephalus. We think that this view may represent one of the 'lost highways' in hydrocephalus research, as described by Jones and Klinge (2008) .
Virtually all cells of the developing mammalian brain are produced in two germinal zones that form the ventricular walls, the VZ and the SVZ (Fig. 1A) (Jacobsen, 1991; Brazel et al., 2003; Gotz and Huttner, 2005; Merkle and Alvarez-Buylla 2006; Malatesta et al., 2008) . The VZ is a pseudostratifi ed neuroepithelium that contains multipotent radial glia/ stem cells, hereafter called neural stem cells (NSCs) . NSCs line the ventricular lumen and through a long basal process reach the pial surface. A landmark of NSCs is their primary cilia that project to the ventricle and are bathed by the fetal cerebrospinal fl uid (CSF, Fig. 1E ) (Mori et al., 2005; Kazanis et al., 2008) . During a fi xed period of brain development, NSCs divide asymmetrically, with one daughter cell remaining as a NSC and the other becoming a neural progenitor cell (NPC). Late in development a population of NSCs diff erentiates into immature ependyma, which during the fi rst postnatal week mature into ependyma (mouse) (Fig. 1A) . In the human, ependymal cell diff erentiation starts at about the fourth week of gestation and is completed around the 22nd gestational week (Sarnat, 1992) . The SVZ is located underneath the VZ along the lateral walls of the lateral ventricles of the embryonic brain; it contains the neural precursors, which lose contact with the ventricular surface, proliferate extensively and then diff erentiate into migratory neuroblasts (Fig. 1A) (Brazel et al., 2003; Bonfanti and Peretto, 2007) .
Over the years, based on our own and other investigators' evidence, we have progressively come to the view that a disruption of the VZ and SVZ, in most cases due to genetic defects, triggers onset of congenital hydrocephalus and abnormal neurogenesis (Fig. 1B) . We discuss this evidence in the present review.
CELLULAR AND MOLECULAR MECHANISMS OF VENTRICU-LAR ZONE DISRUPTION
For clarifi cation purposes we shall defi ne the terms used in the present paper to refer to the VZ. At stages of development when the VZ is mostly formed by radial glia/NSCs, the acronym "VZ" will be used. When the VZ is mostly or exclusively formed by multiciliated ependymal cells, the term "ependyma" will be used. The terms "denudation", "disruption" or "loss" will be alternatively used to refer to the disassembling, disorganization, or loss of the VZ cells.
The disruption of the VZ follows a program that has temporal and spatial patterns, progressing as a "tsunami" wave running from the caudal to rostral regions of the developing ventricular system, leaving behind a severe damage. Radial glial/neural stem cells, immature ependyma and mature ependyma all have distinct phenotypes and certainly play quite different roles (Kazanis et al., 2008) . What do they have in common so that the denudation wave will hit them all? Junctional proteins appear to be the key to understanding this devastating phenomenon. Up to embryonic day 12 (E12), neuroepithelial cells lining the neural tube are joined together by gap, adherens and tight junctions (Fig. 1A ) (Mori et al., 2005; Kazanis et al., 2008) . From E12 onward, tight junctions are missing and cell-to-cell adhesion relies on gap and adherens junctions. It is exactly at this time, E12, when disruption of the VZ starts in the mutant hyh mouse (Jiménez et al., 2001) (Fig. 1A) . What do all the diff erent mutant mouse strains undergoing VZ denudation have in common? Overall, a series of fi ndings indicates that disruption of the VZ arises from a fi nal common pathway involving alterations of vesicle traffi cking, abnormal cell junctions and loss of VZ integrity (Ferland et al., 2009) .
Cadherins play a key role during neural tube formation (Ivanov et al., 2001) and represent the major calciumdependent cell junction molecule in the VZ and later in the ependyma (Fig. 1A , 2A-E) (Hatta et al., 1987; Chenn et al., 1998) . Antibodies against chicken N-cadherin injected into the fetal CSF disrupt the VZ and lead to denudation of the SVZ and formation of periventricular rosettes (Ganzler-Odenthal et al., 1998) . In the hyh mouse the mutated gene encodes for αSnap (Chae et al., 2004) , a key protein in intracellular traffi cking. This mutation results in abnormal transport of N-cadherin to the plasma membrane of NSCs (Chae et al., 2004) . As discussed below, these mice undergo a massive disruption of the VZ. Disruption of the VZ occurs in mice in which adherens junction formation has been impaired by removal of regulatory molecules such as Lgl1 (Klezovitch et al., 2004) , atypical protein kinase C-lambda (aPKCλ) (Imai et al., 2006) , and non-muscle myosin II-B (NMII-b) . Various other animal models with a defect in cell-cell junctions undergo VZ disruption, abnormal translocation of cells into the ventricle and hydrocephalus (Kamiguchi et al., 1998; Tullio et al., 2001; Bátiz et al., 2009) .
Gap junctions are now regarded not only as channels between neighboring cells, but also as signaling complexes that regulate cell function (Saez et al., 2003; Dbouk et al., 2009) . Connexins also form functional hemichannels that provide a pathway linking the intra and extra-cellular milieu (Saez et al., 2005; Dbouk et al., 2009; Orellana et al., 2009) . Gap junctions play an important role in cell-cell coupling to maintain synchronized ependymal ciliary beating (Goodenough et al., 1996; Perez Velazquez et al., 2000; Rouach et al., 2002) and CSF fl ow (Banizs et al., 2005) . A series of studies indicates that the formation of gap and adherens junctions are interrelated phenomena (Jongen et al., 1991; Meyer et al., 1992; Fujimoto et al., 1997; Wei et al., 2005; Oka et al., 2006; Laird 2006; Derangeon et el., 2009 ). This may explain how in the SA of Spina Bifi da Aperta (SBA) patients the same VZ cells display abnormalities in both N-cadherin and connexin 43 ( Fig. 2E-H ) (Sival et al., 2011) .
Recently we have demonstrated that the VZ/ependymal cells of human fetuses are joined together by N-cadherin-based adherens junctions and gap junctions (Guerra et al., 2010; Sival et al., 2011) . In SBA patients, areas of SA about to become denuded display disorganized VZ/ependyma cells with an abnormal subcellular location of N-cadherin and connexin 43 ( Fig. 2D-H) . This mirrors what is seen in animal models with a defect in cell-cell junctions. The increased amount of both junction proteins in the cytoplasm of the abnormal VZ cells might refl ect abnormalities in their transport to the plasma membrane or, less likely, in their internalization and degradation (see Laird 2006) .
In brief, abnormal cell junctions of the VZ cells appear as a fi nal common pathway in the alteration of a series of molecules directly or indirectly involved in the assembly of adherens and gap junctions (Chae et al., 2004; Ferland et al., 2009; Sival et al., 2010; Bátiz et al., 2006; Klezovitch et al., 2004; Imai et al., 2006; Ma et al., 2007; Rasin et al., 2007; Nechiporuk et al., 2007) . This may explain how a series of diff erent genetic defects aff ecting the VZ/ependyma fi nally leads to its disruption, hydrocephalus and abnormal neurogenesis.
A recent fi nding has shown that non-genetic mechanisms can also lead to VZ disruption (Fig. 1B) . Lysophosphatidic acid, a blood-borne factor found in intracranial haemorrhages, binds to receptors expressed by the VZ cells and triggers VZ disruption and hydrocephalus (Yung et al., 2011) .
DISRUPTION OF THE VENTRICULAR ZONE OF THE SYLVIAN AQUEDUCT LEADS TO HYDROCEPHALUS
We have extensively studied the mutant mouse hyh (hydrocephalus with hop gait) that develops fetal onset hydrocephalus. This mutant displays certain characteristics that make it an appropriate animal model of congenital hydrocephalus. Phenotypical characteristics, such as time of onset, type of abnormal CSF dynamics, clinical evolution, and survival/death rate (Jiménez et al., 2001; Wagner et al., 2003; Bátiz et al., 2005; Páez et al., 2007) , are similar to those found in several types of human congenital hydrocephalus.
In the hyh mouse, a programmed disruption of the VZ of the ventral wall of the aqueduct (SA) starts early in fetal life (E12.5) (Fig. 1A) and precedes the onset of a moderate Figure A . There are areas with normal location of N-cadherin (full white arrow), others with little or no N-cadherin (asterisk) and still with cells loaded with this protein (red arrow). E, F, Confocal microscopy of ependyma with normal (E, white arrow) and abnormal (F, red arrow) expression of N-cadherin. n, cell nucleus. G, H, Confocal microscopy of ependyma with normal (E, white arrow) and abnormal (F, orange arrow) expression of connexin 43. n, cell nucleus. I-L, Telencephalon of a hydrocephalic human fetus, 40 weeks gestational age. I, In the lateral ventricle there are large areas devoid of ependyma (black arrows) and others lined by ependyma (blue arrows). J, Area of normal ependyma similar to that framed in communicating hydrocephalus. The loss of the ependyma of the dorsal wall of the SA occurring shortly after birth leads to fusion of the denuded ventral and dorsal walls of SA, resulting in aqueductal obliteration (Fig. 3E ) and severe hydrocephalus ( Fig. 3F) (Jiménez et al., 2001; Wagner et al., 2003; Páez et al., 2007) . The phenomenon of VZ denudation associated with the onset of hydrocephalus has also been found in several mutant mice (Klezovitch et al., 2004; Imai et al., 2006; Ma et al., 2007; Rasin et al., 2007; Nechiporuk et al., 2007) . Moreover, in human hydrocephalic fetuses, VZ/ ependymal denudation precedes, and probably triggers the onset of hydrocephalus (Domínguez-Pinos et al., 2005; Sival et al., 2011) . It can be postulated, on solid grounds, that a primary alteration of the VZ due to various genetic defects triggers the onset of congenital hydrocephalus (Fig.  3) . The loss of the VZ may trigger hydrocephalus through two diff erent mechanisms. First, the abnormal expression of connexin 43 and the loss of the ependyma in the SA imply the abnormal function or the absence of multiciliated cells; consequently the fl ow of CSF through the aqueduct would be curtailed. Later, the complete loss of ependyma (perinatal period) leads to fusion of the denuded neuropiles and stenosis/obliteration of the SA. Collectively, these alterations cause severe hydrocephalus (Fig. 3A, E, F) .
DISRUPTION OF THE VENTRICULAR ZONE OF THE TELEN-CEPHALON LEADS TO ABNORMAL NEUROGENESIS
In hyh mutant mice, the disruption of the VZ follows a program that has temporal and spatial patterns. The program is turned on at E12 (Fig. 1A) and turned off by the end of the second postnatal week. After the third postnatal week, and throughout the life span, the denuded areas remain devoid of ependyma (Fig. 3F) . Spatially, the loss of the VZ progresses as a "tsunami" wave running from caudal to rostral regions of the developing ventricular system, leaving behind a severe damage (Fig. 1C, E, 3D ) (Jiménez et al., 2001; Wagner et al., 2003; Páez et al., 2007) . Disruption of the VZ after birth implies the loss of ependyma; however, the disruption of the VZ during fetal life results in the loss of NSCs (Fig. 1D, E) and a disorganization of the SVZ, indicating that abnormal neurogenesis and hydrocephalus are linked at the etiological level (Fig. 1B, 3A) .
In the pathophysiologic program of VZ disruption, the loss of VZ/ependyma occurs in specifi c regions of the SA and ventricular walls, and at specifi c stages of brain development. This explains why only certain brain structures have an abnormal development, which in turn results in a specifi c neurological impairment (Jimenez et al., 2001; Wagner et al., 2003; Páez et al., 2007) .
HOW AND TO WHAT EXTENT ARE THE PROLIFERATION, MI-GRATION AND DIFFERENTIATION OF NEURAL PROGENITOR CELLS OF THE SVZ AFFECTED BY THE LOSS OF THE ADJA-CENT VZ?
Abnormal proliferation of neural progenitors. NPCs divide to generate either two proliferative daughter cells or one or two postmitotic neuronal daughter cells; the former predominates early, with neuron-generating divisions predominating later. In the SVZ of hyh mice, devoid of a VZ, there is an early overproduction of neurons at the expense of progenitor cells; this would explain the progressive loss of progenitor cells in hyh mutants from E12.5 on (Takahashi et al., 1994 Chae et al., 2004) . The loss of the radial glia/neural stem cells forming the VZ is also expected to contribute to a reduced number of SVZ progenitors. There is apparently no information on the proliferative activity of SVZ neural precursors of human fetuses with disruption of the VZ.
Abnormal migration of neuroblasts. In human hydrocephalic fetuses, an abnormal expression of N-cadherin, as seen in SA, has also been found in the VZ/ependyma of the telencephalon (Guerra et al., 2010) . Many of these cases displayed extensive areas of the lateral ventricles with a disruption of the VZ/ ependyma and displacement of NPCs into the ventricle (Fig.  2I-L Impairment of neuronal migration gives rise to several genetic malformations of the developing cortex: lissencephaly (smooth brain), subcortical band heterotopia (heterotopic neurons arrested under the normal cerebral cortex) and periventricular heterotopia (PH) (Barkovich et al.,1991; Ricci et al., 1992; Kamuro and Tenokuchi 1993; Dobyns et al., 1996; Ferland et al., 2009) . PHs are clusters of neuroblast/neurons ectopically positioned along the lateral ventricles ( Fig. 3C ) (Ferland et al., 2009) . Humans with disruption in the VZ of the telencephalon carry PH primarily composed of later-born neurons (Ferland et al., 2009 ). Mutations in either of two human genes, fi lamin A (FLNA) or ADPribosylation factor guanine exchange factor 2 (ARFGEF2), cause PH (Sheen et al., 2001 (Sheen et al., , 2003 . In the mouse, the loss of FlnA function aff ects cell adhesion, disrupts the VZ and impairs neuronal migration. In the hyh mouse (carrying a mutation in αSnap), the progressive denudation of the VZ also leads to PH formation (Chae et al., 2004; Ferland et al., 2009 ). These fi ndings have led to the proposal that PH formation arises from a disruption in the VZ resulting from alterations of vesicle traffi cking and cellcell adhesion (Ferland et al., 2009 ). Furthermore, disruption of the VZ implies the loss of radial glia. Therefore, neuronal migration would be expected to be impaired at the sites of VZ disruption, leading to the formation of PH (Fig. 3C) (de Wit et al., 2008; Ferland et al., 2009 ). Nevertheless, little is known about how much the disruption of the VZ in human fetuses aff ects corticogenesis. This key issue is under current investigation in our laboratories.
Abnormal neuron diff erentiation. In the hyh mutant, the brain cortex is markedly smaller as compared with wildtype embryos (Chae et al., 2004; Páez et al., 2007) and it has excessive early-born neurons (thicker layer VI) and few lateborn neurons (thinner layers II-IV). However, alteration of the cortex is not a widespread phenomenon. The loss of the VZ in specifi c regions of the ventricular walls and at specifi c stages of brain development explains why only certain brain structures have an abnormal development. Thus, in hyh mice and other animal models, the brain cortex is not aff ected homogeneously, with the cingular and frontal cortices being the most altered regions (Jones et al., 1987 Bruni et al., 1988; Páez et al., 2007) .
How does disruption of the VZ affect the two main populations of cortical neurons, gabaergic and glutamatergic, considering that they arise from VZ located at different anatomical sites? In the mouse, most gabaergic neurons originate from the ganglionic eminences (Anderson et al., 1997 (Anderson et al., , 2002 Corbin et al., 2001; Rubenstein, 2001, 2003; Wichterle et al., 2001; Nadarajah and Parnavelas, 2002) . In hyh mice, the disruption of the VZ of the ganglionic eminences occurs from E14 on (Jiménez et al., 2001; Ferland et al., 2009) , thus severely impairing neurogenesis of gabaergic neurons (Vío et al., 2010) . By contrast, disruption of the VZ of the pallium occurs during the late period of development. Here, late glutamatergic neurons and gliogenesis would be expected to be impaired.
There is virtually no information on brain cortex alterations of human cases with disruption of the telencephalic VZ. One study reported a widespread loss and disorganization of the VZ in the brain of children with lissencephaly and other disorders of neuroblast migration (Sarnat et al., 1993) .
AT SITES OF VZ DISRUPTION, NEURAL PROGENITORS OF THE SVZ ARE ABNORMALLY DISPLACED INTO THE VENTRICLE. WHAT IS THEIR FATE?
All mutant mice carrying a disruption of the VZ show neural progenitors reaching the ventricle. A puzzling question is the fate of neural progenitors reaching the ventricle. Do they undergo cell death? Do they get free in the CSF and move to distant locations? Do they continue proliferating in the CSF? The presence of apparently healthy NPCs on the denuded ventricular surface of hydrocephalic human fetuses ( 
ALTERATIONS OF THE MICROENVIRONMENT OF THE NEU-ROGENIC NICHE AFTER DISRUPTION OF THE VZ
The microenvironment of the VZ and SVZ regulates the behavior of neuronal progenitors through diff usible signals (Kazanis et al., 2008) . Many such signals have been found in fetal CSF (fCSF), indicating that fCSF is part of the neurogenic niche (Owen-Lynch et al., 2003; Gato et al., 2005; Miyan et al., 2006; Johanson et al., 2008 Johanson et al., , 2011 Gato and Desmond, 2009) . Two proteomic analyses of fetal CSF of rats and humans have revealed numerous compounds that likely are cues for diff erent phases of neurogenesis (Parada et al., 2005; Zappaterra et al., 2007) . Although the origin of most of these fCSF compounds is unknown, some are secreted by specialized regions of the VZ such as the choroid plexus (Zappaterra et al., 2007; Johanson et al., 2008) and subcommissural organ (Rodríguez et al., 1998; Montecinos et al., 2005 , Vío et al., 2007 . Considering fCSF as part of the microenvironment of the VZ and SVZ, an abnormal hydrocephalic fCSF would be expected to aff ect the VZ and SVZ. Indeed, in vivo and in vitro studies of HTx rats that develop inherited hydrocephalus revealed that changes in fCSF composition may lead to abnormal corticogenesis (Mashayekhi et al., 2002) .
IS THERE AN OPPORTUNITY FOR DIMINISHING/REPAIRING THE DISRUPTION OF THE VZ AND SVZ AND ITS CONSE-QUENCES: ONSET OF HYDROCEPHALUS AND ABNORMAL NEUROGENESIS?
A distinction must be made between (i) brain maldevelopment due a primary pathology of the VZ that precedes or accompanies the onset of hydrocephalus, and (ii) neurological impairment due to brain damage caused by hydrocephalus. The former occurs during development and consequently hydrocephalic neonates are born with a neurological defi cit. Brain damage is a postnatal acquired defect essentially caused by ventricular hypertension and abnormal CSF.
Brain damage is associated with regional ischemia, disruption of white matter pathways and alteration of the microenvironment of neural cells (Del Biggio, 2001 , 2010 . Derivative surgery, the almost exclusive treatment of hydrocephalus today, is aimed to prevent or diminish brain damage. It is clear that hydrocephalic patients improve clinically after shunting or ventriculostomy. The improvement is due to reduced intracranial pressure, which likely increases white matter blood fl ow (Del Bigio., 2001) , and probably to resumption of the clearance role of CSF. However, derivative surgery does not reverse the inborn brain defects. This has led a study group on hydrocephalus to conclude that "Fifty years after the introduction of shunts for the treatment of this previously untreatable disorder, we must acknowledge that the shunt is not a cure for hydrocephalus; it is only a patch" (Bergsneider et al., 2006) . One of the conclusions of the National Institutes of Health-sponsored workshop on "Priorities for hydrocephalus research" held in 2007 was: "The most forward-looking research priorities are for future treatments. These include not only the development of novel medical devices or surgical techniques, which represent a continuation of the fi rst 50 years of hydrocephalus therapeutic research, but also the development of novel therapies that should emerge from improved understanding of the basic biology of hydrocephalus and its impact on the brain…There is a need to determine the potential role of stem cell therapy, for example, to supply trophic agents" (Williams et al., 2007) .
Based on the evidence that the common history of fetal onset hydrocephalus and abnormal neurogenesis begins with disruption of the VZ and SVZ, we have begun to explore strategies for diminishing/repairing such disruptions.
Grafting of stem cells or neurospheres into the CSF.
There is growing evidence that NSC transplantation represents a great opportunity for the treatment of many neurological diseases (Sievertzon et al., 2005; Buddensiek et al., 2010 , Gage, 2000 Armstrong and Svendson, 2000; Weissman, 2000; Neuhuber et al., 2008) . Stem cells used for transplantation into the CNS include mesenchymal stem cells (hMSCs) (Satake et al., 2004) , NSCs (Bai et al., 2003; Buddensiek et al., 2010) and NPCs Ohta et al., 2004 , Wu et al., 2002 . NSCs can be obtained from fetal brain (Gage, 2000) and from regions of the adult brain such as the hippocampal subgranular zone/ dentate gyrus and the subventricular zone (Rietze et al., 2001) . Under certain culture medium conditions, NSCs grow to form "neurospheres" (Park et al., 2008) . Neurospheres are able to generate neurons, astroglia and oligodendroglia (Fig. 4A-J) .
Worth noticing is that fetal and adult CSF is an important component of the microenvironment of NSCs and NPCs during A, Brain of a HTx rat, at PN1, processed for double immunofl uorescence to reveal nestin (red) and caveolin 1 (green). At this age, the dorsal and lateral walls of the lateral ventricles (LV) are lined by neural stem cells (red). These areas can be dissected out and used for NSC cloning. B, The neurosphere assay is a classical neural stem cell culture technique. After an initial dissection of the lateral ventricular wall (step 1), the tissue is transferred to a plastic falcon tube and mechanically disaggregated to obtain a single cell suspension (steps 2, 3). The cells are then cultured in serum-free media in the presence of EGF as a mitogen (step 4). In the course of the fi rst two days in vitro (DIV), the vast majority of differentiated cells die (step 5). The surviving ones undergo cell division and form spherical clones called "neurospheres" (3-4 DIV, step 6). D, D', D'', Phase-contrast micrographs of NSC developing into neurospheres after 4 DIV. Inset: dividing NSC. E, A neurosphere fi xed, embedded in paraffi n, sectioned and stained with toluidine blue. Cells undergoing mitosis are seen. F, A neurosphere cultured in the presence of BrdU, showing that all its cells are proliferative. G, A neurosphere cultured in a medium containing 5% fetal bovine serum (FBS) and devoid of EGF starts to differentiate into neurons (βIII-tubulin, red) and astrocytes (GFAP, green). H, After a few days in vitro in this medium most cells have differentiated into neurons (red) and astrocytes (green). I, J, Cells similar to those seen in Fig. H pre-and post-natal neurogenesis (Johanson et al., 2008 (Johanson et al., , 2011 . Therefore, CSF is expected to be a benefi cial medium for NSC survival. Indeed, NSCs cultured in a medium containing CSF show increased survival and proliferation as compared to standard culture media . Adult human leptomeningeal (intrathecal) CSF is also an appropriate environment for the in vitro survival and diff erentiation of adult human NSCs (Buddensiek et al., 2010) . Successful NSCs transplantation into the ventricular or subarachnoidal CSF also supports the view that CSF is a benefi cial environment for NSCs to survive, growth and migrate (see below).
Current investigations in our laboratories indicate that neurospheres developed from NSCs collected from the SVZ of normal rats (see Fig. 4 ), when cultured in the presence of CSF from normal or hydrocephalic HTx rats, diff erentiate into neurons and glia. It seems likely that NSCs obtained from normal HTx rats, when grafted into a lateral ventricle of hydrocephalic HTx rats, would generate normal neuronal and glial lineages. We have just started exploring this possibility using neurospheres transfected with green fluorescence protein. Our goal is to promote incorporation of the grafted NSCs into the disrupted VZ and SVZ, in order to improve brain functions compromised by hydrocephalus Delivery of NSCs, NPC or MSCs into CSF. CSF transplantation or explantation of stem/progenitor cells is emerging as an alternative to intraparenchymal grafts of therapeutic cells near injured neural tissue. The multifocal nature of multiple sclerosis makes intraparenchymal cellular therapy difficult. However, a hopeful strategy is to use the CSF administration pathway, which has widespread flow capabilities. Mice with experimental autoimmune encephalomyelitis (EAE) were grafted with neurospheres placed into ventricular CSF; the NPCs entered into demyelinating areas, differentiated into mature brain cells and promoted multifocal remyelination and functional recovery (Pluchino et al., 2003) . In mice with induced stroke, NPCs have been administered into the parenchyma near the infarcts and into a lateral ventricle; CSF administration was more effi cient in distributing NPCs to the lesion area . Hippocampus-derived neurosphere cells, isolated from a transgenic rat expressing green fl uorescent protein, were transplanted into the fourth ventricle or cisterna magna of rats with spinal cord injury. The injected cells followed the fl ow of subarachnoidal CSF and survived as clusters on the pial surface of the spinal cord. Notably, a large number of them migrated into the lesion site, integrated into the injured spinal cord and survived within the host spinal cord for as long as 8 months without any tumorigenic changes (Wu et al., 2002 (Wu et al., , 2004 Bai et al., 2003) . NSCs transplanted into the 4th ventricle of animals with injured dorsal roots reached the lesion root and associated with axons in the same manner as Schwann cells (Ohta et al., 2004) . These two experiments indicate that grafted NSCs diff erentiate in a site-dependent manner (see also Rosser et al., 2000) . Another approach has been the delivery of NSCs by lumbar puncture to rats with spine injury; cells travelled through the CSF to the site of injury in the spinal cord, diff erentiated into nestin-positive, immature neurons or glial cells (Satake et al., 2004) and supported neuroprotection and partial recovery of function (Neuhuber et al., 2008) .
Immune cells and immune molecules have been shown to support neurogenesis from NSCs and NPCs in the adult brain (González-Pérez et al., 2010; Molina-Holgado and MolinaHolgado, 2010) . On the other hand, NPCs transplanted into mice after spinal cord injury contributed to functional recovery mostly by inducing microglia/macrophages to express their repairing phenotype secreting factors such as BDNF and noggin (Ziv et al., 2006; Ziv and Schwartz 2008) . The onset of disruption of the VZ is associated with the arrival of microglia/ macrophages. Thus, the possibility of a fascinating cross talk between NSCs undergoing disruption and immune cells is being explored, since it could become a therapeutic target.
